EP Vantage MedTech Half-Year Review 2015
Copyright © 2015, Evaluate Ltd, All rights reserved.
Big Changes for Medtech in First Half of 2015

EP Vantage MedTech 2015 in Review - Report Cover

 

 

The medtech sector is much changed from where it was a year or even six months ago, with some of the biggest names shifting to take a bigger share of the market and others moving out of it altogether, findings show in the EP Vantage Medtech Half-Year Review 2015. 

 

 


Key highlights include:

  • The first half of 2015 saw 86 mergers and acquisitions in the medtech industry, but the figure for the total value of mergers closed is anything but average at a whopping $83 billion 

  • Just $1.6bn was raised in venture funding in the first half, and while in the first half of 2014 there were three rounds of $100m-plus, this time no company has broken the $60m mark 

  • The FDA granted either a first-time premarket approval or a humanitarian device exemption to 26 devices, compared with 33 during the whole of 2014, putting this year on track to see the most device approvals for a decade

Download your copy of the report: